Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001301 · ClinicalTrials.gov registry record

Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
107
Enrollment target

NCT00001301: Completed study, sponsored by National Cancer Institute (NCI).

NCT00001301 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 107 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001301 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
107 participants
Enrollment target

Study Summary

Non-Hodgkin's lymphoma has been studied in the Pediatric Branch for at least 20 years, during which time a number of different treatment protocols have been used. Approximately 110 patients have apparently been cured of their lymphoma. The present protocol has no therapeutic component, but is designed to document the late effects that may have been encountered by our patients, either as a consequence of the disease or its treatment. In essence, patients who consent to participate will be asked a series of questions pertaining to the quality of their life and possible medical problems that they may be encountering. In addition, they will receive a complete physical examination and undergo non-invasive investigations designed to identify the presence of unsuspected late effects. Investigators in the Eye Clinic, Dental Clinic, Audiology, Cardiology and Endocrinology departments will participate in the protocol. As a part of the study, blood samples will be obtained to investigate the possibility that predisposing genetic factors may be identifiable in the patients normal cells (e.g., p53 mutations, evidence of DNA instability). If such abnormalities are detected, blood samples from family members will also be examined to determine whether the defect was inherited.

Trial Details

FieldValue
Enrollment Target 107 participants
Start Date 1992-08
Est. Completion 2000-04

Sponsor

National Cancer Institute (NCI)

3,257 total trials

What the Registry Record Tells You About NCT00001301

The ClinicalTrials.gov registry entry for NCT00001301 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00001301 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00001301 about?

NCT00001301 is a clinical study titled "Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors". Non-Hodgkin's lymphoma has been studied in the Pediatric Branch for at least 20 years, during which time a number of different treatment protocols have been used. Approximately 110 patients have apparently been cured of their lymphoma. The present protocol has no therapeutic component, but is design...

What is the current status of trial NCT00001301?

This trial is currently completed. The enrollment target is 107 participants. The study started on 1992-08. Estimated completion is 2000-04.

Who is sponsoring clinical trial NCT00001301?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.